Tolterodine reduces the number of urge incontinence episodes in patients with an overactive bladder

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 98, Issue 1, 2001, Pages 97-102

  Jacquetin, Bernard ^a   Wyndaele, Jean Jacques ^b  

^a HÔTEL DIEU   (France)

^b ANTWERP UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Overactive bladder; Tolterodine; Urge incontinence

Indexed keywords

PLACEBO; TOLTERODINE;

ADULT; AGED; ARTICLE; BLADDER CAPACITY; BLOOD PRESSURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DETRUSOR MUSCLE; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG SCREENING; DRUG TOLERABILITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MICTURITION; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SYMPTOM; URGE INCONTINENCE; URODYNAMICS; XEROSTOMIA;

EID: 0034869764     PISSN: 03012115     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-2115(00)00561-3     Document Type: Article

References (18)

1. The patient with overactive bladder - Symptoms and quality of life issues
2. Review: Quality-of-life aspects of the overactive bladder and the effect of treatment with tolterodine
3. The overactive bladder: An overview for primary care health providers
4. The overactive bladder: Pharmacologic basis of drug treatment
5. Randomised, double-blind, multi-centre trial on treatment of frequency, urgency and incontinence related to detrusor hyperreactivity: Oxybutynin versus propantheline versus placebo
6. Oxybutynin: A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic use in detrusor instability
7. Identification of medications that cause cognitive impairment in older people: The case of oxybutynin chloride
8. Tolterodine - A new bladder selective muscarinic receptor antagonist: Pre-clinical pharmacological and clinical data
9. Tolterodine - A new bladder selective antimuscarinic agent
10. Urodynamic and other effects of tolterodine: A novel antimuscarinic drug for the treatment of detrusor overactivity
11. Efficacy and safety of tolterodine in patients with detrusor instability: A dose-ranging study
12. Dose-ranging study of tolterodine in patients with detrusor hyperreflexia
13. Tolterodine in the treatment of overactive bladder: Analysis of the pooled phase II efficacy and safety data
14. Placebo - The drug of choice in female motor urge incontinence?
15. Efficacy and safety of two doses of tolterodine versus placebo in patients with detrusor overactivity and symptoms of frequency, urge incontinence, and urgency: Urodynamic evaluation
16. Once daily controlled versus immediate release oxybutynin chloride for urge urinary incontinence
17. Dry mouth with conventional and controlled-release oxybutynin in urinary incontinence
18. Clinical efficacy and safety of tolterodine compared to oxybutynin and placebo in patients with overactive bladder